Communications, Outreach, and Strategic Partnerships

Strategic Partnerships

As a multidisciplinary, trans-divisional technology development initiative, the IMAT Program has established strategic collaborations and partnerships with academia, industry, and other offices and initiatives within the federal government.  These collaborations serve to further promote the advancement of innovative and transformative technologies by fostering meaningful relationships between government, academia, and industry and by capitalizing on the synergies and mutual interests of IMAT and each of its strategic partners listed below.

The Biospecimen Research Network

The Center to Reduce Cancer Health Disparities (CRCHD)

The Clinical Proteomics Technologies for Cancer Initiative

NCI's Office of Biorepositories and Biospecimen Research

Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration (FDA)